Relates to the availability of buprenorphine in opioid treatment programs
Summary
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 6, 2021
Last action Apr 27, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
7
Key actions
0
Committee
3
Amendments
4
Apr 27, 2022
Assembly · Amendment adopted
PRINT NUMBER 705B
Apr 27, 2022
Assembly · Amendment adopted
AMEND AND RECOMMIT TO WAYS AND MEANS
Jan 5, 2022
Assembly · Referred to committee
REFERRED TO WAYS AND MEANS
May 24, 2021
Assembly · Referred to committee
REPORTED REFERRED TO WAYS AND MEANS
May 13, 2021
Assembly · Amendment adopted
PRINT NUMBER 705A
May 13, 2021
Assembly · Amendment adopted
AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE
Jan 6, 2021
Assembly · Referred to committee
REFERRED TO ALCOHOLISM AND DRUG ABUSE
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Linda Rosenthal
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 705
Scope: NY
Hi! I can help you understand A 705. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline